Feedback / Questions
imvotamab (IGM-2323) - IGM Biosciences
https://www.globenewswire.com/news-release/2024/05/08/2878256/0/en/IGM-Biosciences-Announces-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
May 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next